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Monocytes beget Langerhans cells
Much debate has focused on the cellular origin of 
Langerhans cells (LCs), a subset of antigen-presenting den-
dritic cells unique to the epidermis. CD11c+ cells have been 
suggested as an LC precursor, as they are capable of gen-
erating dendritic cells (DCs) in vivo and LCs in vitro with-
out additional cytokines. Recently, Ginhoux and colleagues 
used a mouse skin injury model to identify the circulating LC 
precursor. Because colony-stimulating factor 1 (CSF-1) and 
its receptor (CSF-1R) have been implicated in the generation 
of DCs in mice, knockout mice and repopulation experi-
ments were used to demonstrate that CSF-1R specifically 
is essential for the differentiation of LCs during homeosta-
sis and following UV exposure. Studies with in vivo-labeled 
monocytes indicated that circulating Gr-1hi cells, which are 
classical monocytes, are the direct LC precursors and that 
differentiation follows the same progression as in newborn 
mice. These findings considerably further the understanding 
of the sequence of cellular events that occur during the dif-
ferentiation of LCs. (Nat Immunol 7:265–73, 2006)
Sunshine may be the best defense
Mammalian Toll-like receptors (TLRs) are central players in 
the innate immune response against microbial infection. In 
a recent report, Liu and colleagues found that activation of 
TLRs in human monocytes and macrophages reduced the 
viability of the intracellular pathogen Mycobacterium tuber-
culosis and upregulated expression of the vitamin D recep-
tor and the vitamin D1 hydroxylase genes. Upregulation of 
these vitamin D synthesis genes induced the antimicrobial 
peptide cathelicidin and resulted in the killing of M. tuber-
culosis in monocytes. Thus, TLRs and vitamin D synthesis are 
linked in the innate immune response in humans. These data 
further implicate differences in the abilities of human pop-
ulations to produce vitamin D in susceptibility to bacterial 
infections. Thus, increased melanin, diminished vitamin D 
synthesis, and inefficient cathelicidin mRNA induction sup-
port the observed increased susceptibility to tuberculosis in 
African-American populations. Vitamin D supplementation, 
therefore, may enhance innate immunity to microbial infec-
tions in at-risk populations. (Science 311:1770–3, 2006)
Finally, HLA genes implicated in 
psoriasis are snared
The underlying genetic basis for psoriasis, an inflamma-
tory and hyperproliferative skin disease affecting 2% of the 
United States population, has not been clearly defined. 
Genetic linkage studies have identified multiple loci, includ-
ing the psoriasis susceptibility 1 (PSORS1) locus, which 
resides within the major histocompatibility complex locus. 
The HLA genes have historically been associated with pso-
riasis, although linkage disequilibrium has posed significant 
challenges to confirming this relationship. Nair and col-
leagues recently reported an extensive study using haplotype 
analysis and shotgun sequencing of the 300-kb PSORS1 risk 
region. From this analysis, HLA-Cw6 was identified as the 
major disease allele at the PSORS1 locus on the basis of its 
association with risk haplotypes, recombinant analysis, and 
protein translation variants. Psoriasis is associated with a 
T-cell cytokine profile and is triggered and maintained by 
infiltrating immunocytes, and thus, a role for HLA genes is 
consistent with the immunopathogenesis of psoriasis. (Am J 
Hum Genet 78:827–51, 2006)
More information on the MAPK to 
developmental disorders
Cardio-facio-cutaneous (CFC) syndrome is a complex 
developmental disorder characterized by heart defects, 
mental retardation, skin and hair abnormalities, and dis-
tinct facial phenotypes. These phenotypes overlap with 
the clinical presentations of the related Noonan syndrome 
(NS) and Costello syndrome (CS). Whereas the molecu-
lar basis for CFC syndrome is largely unknown, mutations 
in PTPN11 and HRAS have been identified in NS and CS 
patients, respectively. Because these mutated protein tar-
gets are part of the critical cell-growth RAS–MAPK pathway, 
recent efforts focused on examining additional genes in 
the pathway for mutations in patients with CFC syndrome. 
Niihori and colleagues sequenced components including 
the RAS genes (HRAS, KRAS, and NRAS) and the down-
stream RAF proto-oncogenes (CRAF, BRAF, and ARAF) in 
43 CFC syndrome patients. Mutations were identified in 
both KRAS and BRAF in these individuals. Another recent 
report by Rodriguez-Viciana and colleagues identified 
mutations in 23 CFC syndrome patients in BRAF as well 
as in the downstream effectors of BRAF, MEK1 and MEK2. 
Together, these data clearly indicate that the RAS–RAF–ERK 
pathway is commonly affected in all three of these related 
diseases. Interestingly, Niihori et al. reported that the KRAS 
and BRAF mutants showed similar phenotypes with regard 
to facial and heart abnormalities and mental retardation; 
however, only the BRAF mutations were associated with 
skin abnormalities. Thus, BRAF may play an important role 
in skin, consistent with the identification of mutations in 
BRAF in malignant melanomas. In general, BRAF mutations 
are identified in about 7% of all human cancers. Rodriguez-
Viciana et al. reported that the mutations found in BRAF 
in CFC syndrome patients differed from those identified in 
human cancers, suggesting yet another mechanism for acti-
vation of this pathway. (Nat Genet 38:294–6, 2006; Science 
311:1287–90, 2006)
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